Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) saw unusually-strong trading volume on Friday . Approximately 1,067,037 shares traded hands during trading, an increase of 602% from the previous session's volume of 152,003 shares.The stock last traded at $21.81 and had previously closed at $22.58.
Wall Street Analyst Weigh In
GRDN has been the subject of several recent analyst reports. Truist Financial reaffirmed a "buy" rating and set a $28.00 price objective (up from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th. Raymond James set a $28.00 price objective on shares of Guardian Pharmacy Services and gave the stock an "outperform" rating in a report on Wednesday, May 14th. Finally, Wall Street Zen downgraded shares of Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a report on Saturday.
Check Out Our Latest Analysis on GRDN
Guardian Pharmacy Services Stock Performance
The stock's 50-day moving average price is $23.14 and its 200-day moving average price is $22.00.
Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The business had revenue of $329.31 million for the quarter, compared to the consensus estimate of $321.21 million. Research analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.
Institutional Investors Weigh In On Guardian Pharmacy Services
Hedge funds have recently modified their holdings of the business. R Squared Ltd acquired a new position in shares of Guardian Pharmacy Services during the 4th quarter worth about $30,000. BNP Paribas Financial Markets acquired a new stake in Guardian Pharmacy Services in the fourth quarter valued at about $37,000. Compass Financial Services Inc acquired a new stake in Guardian Pharmacy Services in the fourth quarter valued at approximately $58,000. JPMorgan Chase & Co. acquired a new position in Guardian Pharmacy Services during the 4th quarter worth about $77,000. Finally, Quantbot Technologies LP acquired a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at about $81,000.
About Guardian Pharmacy Services
(
Get Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Featured Articles
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
